Ion Channel Assays Based on Ion and Voltage-sensitive Fluorescent Probes

Expression and Analysis of Recombinant Ion Channels: From Structural Studies to Pharmacological Screening

Volumn , Issue , 2006, Pages 187-211

  González, Jesús E ^a   Worley, Jennings ^a   Van Goor, Fredrick ^a  

^a VERTEX PHARMACEUTICALS   (United States)

Author keywords

Expression of recombinant ion channels; Ion channel assays; Ion sensitive fluorescent probes; Membrane potential probes; Monitoring channel trafficking; Voltage sensitive fluorescent probes

Indexed keywords

EID: 67650227892     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527608095.ch8     Document Type: Chapter

References (71)

1. J. E. Gonzalez, P. A. Negulescu, Intracellular detection assays for highthroughput screening, Curr. Opin. Biotechnol. 1998, 9 (6), 624-631.
2. L. M. Loew, Potentiometric membrane dyes, in Fluorescent and Luminescent Probes for Biological Activity, W.T. Mason (Ed.), Academic Press, San Diego, 1993, pp. 150-160.
3. D. F. Baxter, et al., A novel membrane potential-sensitive fluorescent dye improves cell-based assays for ion channels, J. Biomol. Screen., 2002, 7(1), 79-85.
4. K. L. Whiteaker, S. M. Gopalakrishnan, D. Groebe, C. C. Shieh, U.Warrior, D. J. Burns, M. J. Coghlan,V. E. Scott, M. Gopalakrishnan, Validation of FLIPR membrane potential dye for high throughput screening of potassium channel modulators, J. Biomol. Screen. 2001, (5), 305-312.
5. J. E. Gonzalez, R.Y. Tsien, Voltage sensing by fluorescence resonance energy transfer in single cells, Biophys. J. 1995, 69(4),1272-1280.
6. J. E. Gonzalez, R.Y. Tsien, Improved indicators of cell membrane potential that use fluorescence resonance energy transfer, Chem. Biol. 1997, 4(4), 269-277.
7. R. F. Flewelling,W. L. Hubbell, The membrane dipole potential in a total membrane potential model. Applications to hydrophobic ion interactions with membranes, Biophys. J. 1986, 49 (2), 541-552.
8. K. O. Holevinsky, Z. Fan, M. Frame, J. C. Makielski,V. Groppi, D. J. Nelson, ATP-sensitive K+ channel opener acts as a potent Cl-channel inhibitor in vascular smooth muscle cells, J. Membr. Biol. 1994, 137 (1), 59-70.
9. K. S. Schroeder, B. D. Neagle, FLIPR: A new instrument for accurate, high throughput optical screening, J. Biomol. Screen. 1996, 1, 75-80.
10. J. Farinas, A. W. Chow, H. G. Wada, A microfluidic device for measuring cellular membrane potential, Anal. Biochem. 2001, 295 (2), 138-142.
11. J. E. Gonzalez, M. P. Maher, Cellular fluorescent indicators and voltage/ion probe reader (VIPR) tools for ion channel and receptor drug discovery, Receptors Channels 2002, 8(5-6), 283-295.
12. J. E. Gonzalez, K. Oades,Y. Leychkis, A. Harootunian, P. A. Negulescu, Cell-based assays and instrumentation for screening ion-channel targets, Drug Discov. Today 1999, 4 (9), 431-439.
13. M. Falconer, et al., High-throughput screening for ion channel modulators, J. Biomol. Screen. 2002, 7 (5), 460-465.
14. D. E. Epps, M. L. Wolfe,V. Groppi, Characterization of the steady-state and dynamic fluorescence properties of the potential-sensitive dye bis-(1,3-dibutylbarbituric acid)trimethine oxonol (Dibac4( 3)) in model systems and cells, Chem. Phys. Lipids. 1994, 69(2), 137-150.
15. T. Kenakin, Stimulus-Response Mechanisms, in Pharmacologic Analysis of Drug-Receptor Interaction, Lippincott-Raven, Philadelphia, 1997, pp. 78-105.
16. J. Koester, Membrane Potential, in Principles of Neural Science, E. R. Kandel, J. H. Schwartz,T. M. Jessell (Eds.), Elsevier, New York, 1991, pp. 81-94.
17. C. Wolff, B. Fuks, P. Chatelain, Comparative study of membrane potentialsensitive fluorescent probes and their use in ion channel screening assays, J. Biomol. Screen. 2003, 8 (5), 533-543.
18. W. Tang, J. Kang, X. Wu, D. Rampe, L. Wang, H. Shen, Z. Li, D. Dunnington, T. Garyantes, Development and evaluation of high throughput functional assay methods for HERG potassium channel, J. Biomol. Screen. 2001, 6 (5), 325-331.
19. K. R. Gee, K. A. Brown,W. N. Chen, J. Bishop-Stewart, D. Gray, I. Johnson, Chemical and physiological characterization of fluo-4 Ca(2+)-indicator dyes, Cell Calcium 2000, 27 (2), 97-106.
20. A. Minta, J. P. Kao, R.Y. Tsien, Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores, J. Biol. Chem. 1989, 264(14), 8171-8178.
21. G. Velicelebi, K. A.Stauderman, M. A. Varney, M. Akong, S. D. Hess, E. C. Johnson, Fluorescence techniques for measuring ion channel activity, Methods Enzymol. 1999, 294, 20-47.
22. A. Minta, R. Y. Tsien, Fluorescent indicators for cytosolic sodium, J. Biol. Chem. 1989, 264(32), 19449-19457.
23. G. P. Amorino, M. H. Fox, Intracellular Na+ measurements using sodium green tetraacetate with flow cytometry, Cytometry 1995, 21 (3), 248-256.
24. C. D. Weaver, D. Harden, S. I. Dworetzky, B. Robertson, R. J. Knox, A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells, J. Biomol. Screen. 2004, 9 (8), 671-677.
25. M. R. West, C. R Molloy, A microplate assay measuring chloride ion channel activity, Anal. Biochem. 1996, 241 (1), 51-58.
26. S. Jayaraman, L. Teitler, B. Skalski, A. S. Verkman, Long-wavelength iodide-sensitive fluorescent indicators for measurement of functional CFTR expression in cells, Am. J. Physiol. 1999, 277(5 Pt. 1), C1008-1018.
27. F. Munkonge, et al., Measurement of halide efflux from cultured and primary airway epithelial cells using fluorescence indicators, J. Cystic Fibrosis 2004, 3 (Suppl. 2), 171-176.
28. E. Sullivan, E. M. Tucker, I. L. Dale, Measurement of [Ca2+] using the Fluorometric Imaging Plate Reader (FLIPR), Methods Mol. Biol. 1999, 114, 125-133.
29. G. Grynkiewicz, M. Poenie, R. Y. Tsien, A new generation of Ca2+ indicators with greatly improved fluorescence properties, J. Biol. Chem. 1985, 260 (6), 3440-3450.
30. G. P. Miljanich, Ziconotide: neuronal calcium channel blocker for treating severe chronic pain, Curr. Med. Chem. 2004, 11(23), 3029-3040.
31. K. L. Rogers,W. F. Fong, J. Redburn, L. R. Griffiths, Fluorescence detection of plant extracts that affect neuronal voltage-gated Ca2+ channels, Eur. J. Pharm. Sci. 2002, 15 (4), 321-330.
32. M. Xia, J. P. Imredy, K. S. Koblan, P. Bennett,T. M. Connolly, State-dependent inhibition of L-type calcium channels: cell-based assay in highthroughput format, Anal. Biochem. 2004, 327 (1), 74-81.
33. D. E. Clapham, L. W. Runnels, C. Strubing, The TRP ion channel family, Nat. Rev. Neurosci. 2001, 2(6), 387-396.
34. R. Inoue, TRP channels as a newly emerging non-voltage-gated CA2+ entry channel superfamily, Curr. Pharm. Des. 2005, 11(15), 1899-1914.
35. C. Montell, The TRP superfamily of cation channels, Sci. STKE 2005, (272): re3.
36. N. Lee, et al., Expression and characterization of human transient receptor potential melastatin 3 (hTRPM3), J. Biol. Chem. 2003, 278(23), 20890-20897.
37. L. Mere,T. Bennett, P. Coassin, P. England, B. Hamman,T. Rink, S. Zimmerman, P. Negulescu, Miniaturized FRETassays and microfluidics: key components for ultra-high-throughput screening, Drug Discov. Today 1999, 4 (8), 363-369.
38. H. K. Rami, et al., Discovery of small molecule antagonists of TRPV1, Bioor. Med. Chem. Lett. 2004, 14(14), 3631-3634.
39. H. J. Behrendt,T. Germann, C. Gillen, H. Hatt, R. Jostock, Characterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR) assay, Br. J. Pharmacol. 2004, 141 (4), 737-745.
40. J. Ishikawa, K. Ohga,T. Yoshino, R. Takezawa, A. Ichikawa, H. Kubota, T. Yamada, A pyrazole derivative,YM-58483, potently inhibits store-operated sustained Ca2+ influx and IL-2 production in T lymphocytes, J. Immunol. 2003, 170 (9), 4441-4449.
41. G. Appendino, et al., Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential, J. Pharmacol. Exp. Ther. 2005, 312(2), 561-570.
42. R. W. Fitch,Y. Xiao, K. J. Kellar, J. W. Daly, Membrane potential fluorescence: a rapid and highly sensitive assay for nicotinic receptor channel function, Proc. Natl. Acad. Sci. U S A 2003, 100 (8), 4909-4914.
43. R. G. Vickery, et al., Comparison of the pharmacological properties of rat Na(V)1.8 with rat Na(V)1.2 a and human Na(V)1.5 voltage-gated sodium channel subtypes using a membrane potential sensitive dye and FLIPR, Receptors Channels 2004, 10 (1), 11-23.
44. J. P. Felix, et al., Functional assay of voltage-gated sodium channels using membrane potential-sensitive dyes, Assay Drug Dev. Technol. 2004, 2(3), 260-268.
45. W. A. Carroll, et al., Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridinebased KATP openers that potently inhibit bladder contractions in vitro, J. Med. Chem. 2004, 47(12), 3180-3192.
46. M. Gopalakrishnan, et al., Characterization of the ATP-sensitive potassium channels (KATP) expressed in guinea pig bladder smooth muscle cells, J. Pharmacol. Exp. Ther. 1999, 289(1), 551-558.
47. K. L. Whiteaker, R. Davis-Taber,V. E. Scott, M. Gopalakrishnan, Fluorescence-based functional assay for sarcolemmal ATP-sensitive potassium channel activation in cultured neonatal rat ventricular myocytes, J. Pharmacol.Toxicol. Methods 2001, 46 (1), 45-50.
48. M. Gopalakrishnan, et al., Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K(+) channel Kir6.2 combination expressed in HEK-293 cells, Br. J. Pharmacol. 2000, 129 (7), 1323-1332.
49. G. C. Terstappen, A. Pellacani, L. Aldegheri, F. Graziani, C. Carignani, G. Pula, C. Virginio, The antidepressant fluoxetine blocks the human small conductance calcium-activated potassium channels SK1, SK2 and SK3, Neurosci. Lett. 2003, 346(1-2), 85-88.
50. T. Brismar, S. Anderson,V. P. Collins, Mechanism of high K+ and Tl+ uptake in cultured human glioma cells, Cell Mol. Neurobiol. 1995, 15(3), 351-360.
51. H. P. Moore, M.A Raftery, Direct spectroscopic studies of cation translocation by Torpedo acetylcholine receptor on a time scale of physiological relevance, Proc. Natl. Acad. Sci. USA 1980, 77 (8), 4509-4513.
52. W. C. Wu, H. P. Moore, M. A. Raftery, Quantitation of cation transport by reconstituted membrane vesicles containing purified acetylcholine receptor, Proc. Natl. Acad. Sci. USA 1981, 78(2), 775-779.
53. R. S. Hoffman, Thallium toxicity and the role of Prussian blue in therapy,Toxicol. Rev. 2003, 22 (1), 29-40.
54. C. E. Adkins, et al., GABA(A) receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential, J. Biol. Chem. 2001, 276(42), 38934-38939.
55. A. J. Smith, P. B. Simpson, Methodological approaches for the study of GABA( A) receptor pharmacology and functional responses, Anal. Bioanal. Chem. 2003, 377 (5), 843-851.
56. A. J. Smith, B. Oxley, S. Malpas, G. V. Pillai, P. B. Simpson, Compounds exhibiting selective efficacy for different beta subunits of human recombinant gamma-aminobutyric acid A receptors, J. Pharmacol. Exp. Ther. 2004, 311 (2), 601-609.
57. G. V. Pillai, A. J. Smith, P. A. Hunt, P. B. Simpson, Multiple structural features of steroids mediate subtype-selective effects on human alpha 4 beta 3 delta GABAA receptors, Biochem. Pharmacol. 2004, 68 (5), 819-831.
58. P. M. Quinton, Missing Cl conductance in cystic fibrosis, Am. J. Physiol. 1986, 251(4 Pt. 1), C649-652.
59. J. R. Riordan, et al., Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, Science 1989, 245(4922), 1066-1073.
60. R. C. Boucher, New concepts of the pathogenesis of cystic fibrosis lung disease, Eur. Respir. J. 2004, 23 (1), 146-58.
61. H. Yang, et al., Nanomolar affinity small molecule correctors of defective References 211 Delta F508-CFTR chloride channel gating, J. Biol. Chem. 2003, 278(37), 35079-35085.
62. R. M. Wachter, S.J Remington, Sensitivity of the yellow variant of green fluorescent protein to halides and nitrate, Curr. Biol. 1999, 9(17), R628-629.
63. R. M. Wachter, D. Yarbrough, K. Kallio, S. J. Remington, Crystallographic and energetic analysis of binding of selected anions to the yellow variants of green fluorescent protein, J. Mol. Biol. 2000, 301 (1), 157-171.
64. A. S. Verkman, S. Jayaraman, Fluorescent indicator methods to assay functional CFTR expression in cells, Methods Mol. Med. 2002, 70, 187-196.
65. T. Kuner, G. J. Augustine, A genetically encoded ratiometric indicator for chloride: capturing chloride transients in cultured hippocampal neurons, Neuron 2000, 27 (3), 447-459.
66. R. C. Rubenstein, M. E. Egan, P. L. Zeitlin, In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR, J. Clin. Invest. 1997, 100(10), 2457-65.
67. R. C. Rubenstein, P. L. Zeitlin, A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function, Am. J. Respir. Crit. Care Med. 1998, 157 (2), 484-490.
68. B. D. Moyer, B.A Stanton, Analysis of CFTR trafficking and polarization using green fluorescent protein and confocal microscopy, Methods Mol. Med. 2002, 70, 217-227.
69. C. R. Valdivia, et al., A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs, Cardiovasc. Res. 2004, 62 (1), 53-62.
70. E. Ficker, C. A. Obejero-Paz, S. Zhao, A. M. Brown, The binding site for channel blockers that rescue misprocessed human long QTsyndrome type 2 ether-a-gogo-related gene (HERG) mutations, J. Biol. Chem. 2002, 277 (7), 4989-4998.
71. F. Yan, C. W. Lin, E. Weisiger, E. A. Cartier, G. Taschenberger, S. L. Shyng, Sulfonylureas correct trafficking defects of ATP-sensitive potassium channels caused by mutations in the sulfonylurea receptor, J. Biol. Chem. 2004, 279(12), 11096-11105.